Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
809.00    1.00 (0.12%)
Bid:
808.00
Ask:
810.00
Spread: 2.00 (0.248%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Interim Management Statement

12 May 2014 11:02

RNS Number : 8360G
Savills PLC
12 May 2014
 



 

12 May 2014

 

SAVILLS PLC

("Savills" or "the Company")

 

AGM Statement and Interim Management Statement

 

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 12 noon, 33 Margaret Street, London, W1G 0JD, and provides the following Interim Management Statement (IMS) for the period to 12 May 2014.

 

During the first four months of the year Savills has traded as anticipated with continued growth in the UK, and a robust performance in both Asia and Continental Europe. Our US business has an improved pipeline and Cordea Savills, the Group's investment management business, has traded in line with our expectations of revenue and profit growth.

 

In the UK commercial markets Savills has continued to maintain a significant share of the Prime Central London investment and leasing markets, although, as anticipated, the shortage of supply of investment stock has become increasingly apparent. Growth in investment volume outside London has continued from last year and development activity has further increased. We continue to expect regional recovery to be the primary driver of growth for our UK commercial business in 2014.

 

The UK Prime Residential market has continued to perform well with year on year increases in both volume and value. As anticipated, we have lately seen some cooling in the Prime and Super Prime Central London market. In contrast, there remains strong demand for property in the £1 million-£2 million price segments of the North, East and South West London regions. The regional UK residential market is continuing to recover with growing volumes and a significant increase in buyers registering with Savills.

 

In Asia Pacific, allowing for the material fall in trading volumes in Hong Kong in comparison with the same period last year, business has performed in line with expectations. Our Japanese business has continued to grow substantially as a result of the sustained strength of the Tokyo commercial investment market during the period. In mainland China, despite a slow down in transaction markets, revenue and earnings have grown in line with our expectations thanks to the growth of our Property Management business.

 

In Continental Europe, to date we have traded in line with our expectations, with strengthening performance in the transaction markets of Ireland, Spain, Germany and France.

 

Globally, our Consultancy business has experienced continued revenue growth with particular strengths in UK Development consultancy and UK/Continental European Valuation consultancy. The Property Management business has delivered a solid increase in revenue, particularly in the UK and in Asia where we continued to grow our market share in the core markets of Hong Kong and China.

 

Following a strong year of capital raising in 2013, Cordea Savills has grown revenue and profits in line with our expectations for the period to date, whilst continuing to experience significant capital inflows.

 

In the US, the existing Savills business has performed in line with expectations and our proposed acquisition of Studley Inc. was unanimously approved at the Studley Stockholder meeting held yesterday. Pending expiry of the Hart-Scott-Rodino Antitrust notification period, it is anticipated that the transaction will be completed on 30th May 2014.

 

 

For further information, contact:

 

Savills 020 7409 8934

Jeremy Helsby, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

Peter Hewer

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAESAFEFLEFF
Date   Source Headline
1st Jun 202611:29 amRNSTotal Voting Rights
22nd May 202610:09 amRNSDirector/PDMR Shareholding
14th May 202612:41 pmRNSResult of AGM
13th May 20264:16 pmRNSResult of AGM
13th May 20267:00 amRNSAGM Statement
12th May 20263:41 pmRNSDirector/PDMR Shareholding
7th May 20263:39 pmRNSDirector Declaration
29th Apr 20263:04 pmRNSReplacement - Director/PDMR Shareholding
29th Apr 20261:23 pmRNSDirector/PDMR Shareholding
28th Apr 20261:58 pmRNSDirector/PDMR Shareholding
13th Apr 20265:24 pmRNSHolding(s) in Company
13th Apr 20262:10 pmRNSDirector/PDMR Shareholding
7th Apr 20264:03 pmRNSAnnual Report and AGM Notice
1st Apr 202610:00 amRNSTotal Voting Rights
31st Mar 202612:55 pmRNSDirector/PDMR Shareholding
26th Mar 20268:57 amRNSDirector/PDMR Shareholding
24th Mar 202611:02 amRNSDirector/PDMR Shareholding
23rd Mar 20269:27 amRNSDirector/PDMR Shareholding
18th Mar 20263:47 pmRNSDirector/PDMR Shareholding
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:33 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 20262:00 pmRNSHolding(s) in Company
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:51 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
16th Mar 202611:49 amRNSDirector/PDMR Shareholding
13th Mar 20261:34 pmRNSDirector/PDMR Shareholding
13th Mar 20261:32 pmRNSDirector/PDMR Shareholding
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:26 amRNSSignificant Transaction
12th Mar 20267:08 amRNSFinal Results
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
11th Mar 20264:21 pmRNSDirector/PDMR Shareholding
5th Mar 20265:00 pmRNSHolding(s) in Company
2nd Mar 20269:11 amRNSTotal Voting Rights
25th Feb 202611:14 amRNSHolding(s) in Company
11th Feb 20264:07 pmRNSDirector/PDMR Shareholding
4th Feb 20265:29 pmRNSHolding(s) in Company
2nd Feb 20265:32 pmRNSTotal Voting Rights
19th Jan 20268:30 amRNSDirectorship change
15th Jan 20267:00 amRNSYear End Trading Update
13th Jan 20265:40 pmRNSDirector/PDMR Shareholding
13th Jan 202612:59 pmRNSHolding(s) in Company
2nd Jan 20263:00 pmRNSTotal Voting Rights
11th Dec 20252:00 pmRNSDirector/PDMR Shareholding
1st Dec 20259:49 amRNSTotal Voting Rights
11th Nov 20254:58 pmRNSDirector/PDMR Shareholding
3rd Nov 202512:32 pmRNSTotal Voting Rights
13th Oct 20251:33 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.